Literature DB >> 10475801

Chronic myeloid leukemia.

I Nash.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10475801     DOI： 10.1056/NEJM199909023411016

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Potential role of Wnt/β-catenin signaling in blastic transformation of chronic myeloid leukemia: cross talk between β-catenin and BCR-ABL.

Authors:  Jing Hu; Min Feng; Zhang-Ling Liu; Yi Liu; Zheng-Lan Huang; Hui Li; Wen-Li Feng
Journal:  Tumour Biol       Date:  2016-11-05

2.  A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate.

Authors:  Min Sik Kim; Dong Hyun Lee; Yu Rim Lee; Dong Kyun Kim; Suk Hyang Bae; Jin Yeon Hwang; Kyung A Kwon; Suee Lee; Jin Yeong Han; Ki Uk Kim; Sung-Hyun Kim
Journal:  Korean J Hematol       Date:  2010-03-31

3.  Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population.

Authors:  Yanmin Zhao; Lizhen Liu; Yingjia Wang; Gongqiang Wu; Xiaoyu Lai; Weijie Cao; Yi Luo; Yamin Tan; Jimin Shi; Wanzhuo Xie; Xiujin Ye; Zhen Cai; Maofang Lin; He Huang
Journal:  Int J Hematol       Date:  2009-04-07       Impact factor: 2.490

4.  Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients.

Authors:  Mei-Yong Li; Cui Zhao; Lian Chen; Fang-Yi Yao; Fang-Min Zhong; Ying Chen; Shuai Xu; Jun-Yao Jiang; Yu-Lin Yang; Qing-Hua Min; Jin Lin; Hai-Bin Zhang; Jing Liu; Xiao-Zhong Wang; Bo Huang
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

5.  Acute subdural hematoma due to acute myeloid leukemia and B-cell lymphoma.

Authors:  Denis Babici; Pamraj Sharma; Jason DeGregorio; Brian Snelling; Khalid Hanafy
Journal:  eNeurologicalSci       Date:  2022-09-15

6.  Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia.

Authors:  Fangyi Yao; Cui Zhao; Fangmin Zhong; Tingyu Qin; Shuqi Li; Jing Liu; Bo Huang; Xiaozhong Wang
Journal:  PeerJ       Date:  2022-01-18       Impact factor: 2.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.